Back to top

IMMX Maintained by Morgan Stanley -- Price Target Lowered to $19

IMMX Maintained by Morgan Stanley -- Price Target Lowered to $19

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Immix Biopharma, Inc. (IMMX)